The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(4-chlorophenyl)-2-cyclohexyl-10-methylpyrimido[4,5-b]quinoline-4,5(3H,10H)-dione ID: ALA4789255
PubChem CID: 85090329
Max Phase: Preclinical
Molecular Formula: C24H22ClN3O2
Molecular Weight: 419.91
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cn1c2ccccc2c(=O)c2c(=O)n(-c3ccc(Cl)cc3)c(C3CCCCC3)nc21
Standard InChI: InChI=1S/C24H22ClN3O2/c1-27-19-10-6-5-9-18(19)21(29)20-23(27)26-22(15-7-3-2-4-8-15)28(24(20)30)17-13-11-16(25)12-14-17/h5-6,9-15H,2-4,7-8H2,1H3
Standard InChI Key: NJHFAARZJJDXBG-UHFFFAOYSA-N
Molfile:
RDKit 2D
30 34 0 0 0 0 0 0 0 0999 V2000
17.8373 -2.6031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8361 -3.4301 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5506 -3.8428 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5488 -2.1905 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2639 -2.5995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2647 -3.4260 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9797 -3.8368 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.9740 -2.1854 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6897 -2.5925 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6933 -3.4218 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4121 -3.8315 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.1279 -3.4131 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1202 -2.5807 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.4008 -2.1747 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9697 -1.3608 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.3936 -1.3500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.8251 -2.1625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5435 -2.5698 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2532 -2.1514 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2459 -1.3258 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5227 -0.9205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8160 -1.3414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8404 -3.8192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8445 -4.6448 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5576 -5.0519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2712 -4.6379 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2672 -3.8123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5495 -3.4006 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9555 -0.9058 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
19.9819 -4.6614 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 10 1 0
9 8 1 0
8 5 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 1 0
14 9 1 0
8 15 2 0
14 16 2 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
13 17 1 0
23 24 1 0
23 28 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 28 1 0
12 23 1 0
20 29 1 0
7 30 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 419.91Molecular Weight (Monoisotopic): 419.1401AlogP: 4.94#Rotatable Bonds: 2Polar Surface Area: 56.89Molecular Species: NEUTRALHBA: 5HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 5.51CX LogD: 5.51Aromatic Rings: 4Heavy Atoms: 30QED Weighted: 0.43Np Likeness Score: -0.89
References 1. Luderman KD,Jain P,Benjamin Free R,Conroy JL,Aubé J,Sibley DR,Frankowski KJ. (2021) Development of pyrimidone D1 dopamine receptor positive allosteric modulators., 31 [PMID:33221389 ] [10.1016/j.bmcl.2020.127696 ]